Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2

Nicole V Tolan1, Gary L Horowitz2

  • 1Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Cotran 2, Boston, MA 01752, USA.

Summary

Rapid point-of-care (POC) SARS-CoV-2 nucleic acid amplification tests (NAATs) addressed pandemic needs for quick results. Validation is crucial to ensure these tests meet performance standards for clinical use.

Related Concept Videos